• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers.

作者信息

Bavishi Chirag, Maddox Thomas M, Messerli Franz H

机构信息

Division of Cardiology, Warren Alpert Medical School of Brown University, Lifespan Cardiovascular Institute, Providence, Rhode Island.

Division of Cardiology, Washington University School of Medicine in St Louis, St Louis, Missouri.

出版信息

JAMA Cardiol. 2020 Jul 1;5(7):745-747. doi: 10.1001/jamacardio.2020.1282.

DOI:10.1001/jamacardio.2020.1282
PMID:32242890
Abstract
摘要

相似文献

1
Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers.2019冠状病毒病（COVID-19）感染与肾素-血管紧张素系统阻滞剂
JAMA Cardiol. 2020 Jul 1;5(7):745-747. doi: 10.1001/jamacardio.2020.1282.
2
[Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].[年龄、合并症及肾素-血管紧张素-醛固酮系统在新型冠状病毒肺炎中的作用。血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂的影响]
Kardiologiia. 2020 Apr 8;60(4):4-9. doi: 10.18087/cardio.2020.4.n1122.
3
Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂对无高血压的新冠患者有益吗？
Pharmacol Res. 2020 Sep;159:104959. doi: 10.1016/j.phrs.2020.104959. Epub 2020 Jun 4.
4
Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.肾素-血管紧张素-醛固酮系统阻滞剂在新型冠状病毒肺炎患者中的疗效：一项系统评价和荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):335-337. doi: 10.1093/ehjcvp/pvaa074.
5
Drugs and the renin-angiotensin system in covid-19.新冠病毒肺炎中的药物与肾素-血管紧张素系统
BMJ. 2020 Apr 2;369:m1313. doi: 10.1136/bmj.m1313.
6
Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.肾素-血管紧张素-醛固酮系统抑制剂与新型冠状病毒肺炎患者的预后：一项病例系列研究。
Hypertension. 2020 Aug;76(2):e10-e12. doi: 10.1161/HYPERTENSIONAHA.120.15312. Epub 2020 May 8.
7
Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.肾素-血管紧张素-醛固酮系统抑制剂治疗高血压患者可降低COVID-19死亡率：一项荟萃分析
Hypertension. 2020 Aug;76(2):e13-e14. doi: 10.1161/HYPERTENSIONAHA.120.15572. Epub 2020 May 27.
8
Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis.内源性血管紧张素 II 中毒：COVID-19 假说。
Front Immunol. 2020 Jun 19;11:1472. doi: 10.3389/fimmu.2020.01472. eCollection 2020.
9
[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].[肾素-血管紧张素系统（RAS）与2019冠状病毒病——关于RAS阻滞剂的处方]
Pneumologie. 2020 Sep;74(9):611-614. doi: 10.1055/a-1165-6994. Epub 2020 Sep 11.
10
Angiotensin receptor blockers for the treatment of COVID-19 and its comorbidities.用于治疗新型冠状病毒肺炎及其合并症的血管紧张素受体阻滞剂
Pharmacol Res. 2020 Sep;159:104958. doi: 10.1016/j.phrs.2020.104958. Epub 2020 May 28.

引用本文的文献

1
Evaluating the Role of the Renin-angiotensin System in COVID-19: Implications for ACE Inhibitor and ARB Use During SARS-CoV-2 Infection.评估肾素-血管紧张素系统在2019冠状病毒病中的作用：对严重急性呼吸综合征冠状病毒2感染期间使用血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体拮抗剂的启示
J Cell Immunol. 2024;6(6):255-265. doi: 10.33696/immunology.6.213.
2
COVID-19 and cardiovascular comorbidities: An update.新型冠状病毒肺炎与心血管合并症：最新进展
Rev Port Cardiol (Engl Ed). 2020 Aug;39(8):417-419. doi: 10.1016/j.repce.2020.06.002. Epub 2020 Dec 16.
3
Serum ACE2 and S19P gene polymorphism in Egyptian patients with COVID-19 infection: correlation with disease severity.
埃及新冠肺炎感染患者的血清血管紧张素转换酶2（ACE2）和S19P基因多态性：与疾病严重程度的相关性
Sci Rep. 2024 Mar 10;14(1):5846. doi: 10.1038/s41598-024-56260-6.
4
Cereals as a Source of Bioactive Compounds with Anti-Hypertensive Activity and Their Intake in Times of COVID-19.谷物作为具有抗高血压活性的生物活性化合物来源及其在 COVID-19 时期的摄入量
Foods. 2022 Oct 16;11(20):3231. doi: 10.3390/foods11203231.
5
Effect of the chronic medication use on outcome measures of hospitalized COVID-19 patients: Evidence from big data.慢性药物治疗对住院 COVID-19 患者结局测量指标的影响：来自大数据的证据。
Front Public Health. 2023 Feb 24;11:1061307. doi: 10.3389/fpubh.2023.1061307. eCollection 2023.
6
Altered microRNA Transcriptome in Cultured Human Airway Cells upon Infection with SARS-CoV-2.感染 SARS-CoV-2 后培养的人呼吸道细胞中微小 RNA 转录组的改变。
Viruses. 2023 Feb 10;15(2):496. doi: 10.3390/v15020496.
7
, a natural pharmacy against COVID-19: A molecular review.对抗新冠病毒的天然药房：分子综述
J Herb Med. 2023 Mar;38:100635. doi: 10.1016/j.hermed.2023.100635. Epub 2023 Jan 26.
8
Effects of angiotensin receptor blockers (ARBs) on clinical outcomes of patients with hypertension and COVID-19: A 7-month follow-up cohort study.血管紧张素受体阻滞剂（ARBs）对高血压合并新型冠状病毒肺炎（COVID-19）患者临床结局的影响：一项为期7个月的随访队列研究。
J Cardiovasc Thorac Res. 2022;14(4):253-257. doi: 10.34172/jcvtr.2022.30559. Epub 2022 Nov 26.
9
Ageism and the Pandemic: Risk and Protective Factors of Well-Being in Older People.年龄歧视与大流行：老年人幸福感的风险和保护因素
Geriatrics (Basel). 2023 Jan 16;8(1):14. doi: 10.3390/geriatrics8010014.
10
Association between Vitamin D Status and Secondary Infections in Patients with Severe COVID-19 Admitted in the Intensive Care Unit of a Tertiary-Level Hospital in Turkey.土耳其一家三级医院重症监护病房收治的重症 COVID-19 患者维生素 D 状态与继发感染之间的关联
Diagnostics (Basel). 2022 Dec 26;13(1):59. doi: 10.3390/diagnostics13010059.